Cargando…
Additional antibody suppression from rituximab added to conventional therapy in severe, refractory anti-GBM nephritis
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421516/ https://www.ncbi.nlm.nih.gov/pubmed/25949452 http://dx.doi.org/10.1093/ndtplus/sfq085 |
| _version_ | 1782369887096668160 |
|---|---|
| author | Mutsaers, Pim Selten, Heidi van Dam, Bastiaan |
| author_facet | Mutsaers, Pim Selten, Heidi van Dam, Bastiaan |
| author_sort | Mutsaers, Pim |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4421516 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2010 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-44215162015-05-06 Additional antibody suppression from rituximab added to conventional therapy in severe, refractory anti-GBM nephritis Mutsaers, Pim Selten, Heidi van Dam, Bastiaan NDT Plus Letter to the Editor Oxford University Press 2010-08 2010-05-13 /pmc/articles/PMC4421516/ /pubmed/25949452 http://dx.doi.org/10.1093/ndtplus/sfq085 Text en © The Author 2010. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Letter to the Editor Mutsaers, Pim Selten, Heidi van Dam, Bastiaan Additional antibody suppression from rituximab added to conventional therapy in severe, refractory anti-GBM nephritis |
| title | Additional antibody suppression from rituximab added to conventional therapy in severe, refractory anti-GBM nephritis |
| title_full | Additional antibody suppression from rituximab added to conventional therapy in severe, refractory anti-GBM nephritis |
| title_fullStr | Additional antibody suppression from rituximab added to conventional therapy in severe, refractory anti-GBM nephritis |
| title_full_unstemmed | Additional antibody suppression from rituximab added to conventional therapy in severe, refractory anti-GBM nephritis |
| title_short | Additional antibody suppression from rituximab added to conventional therapy in severe, refractory anti-GBM nephritis |
| title_sort | additional antibody suppression from rituximab added to conventional therapy in severe, refractory anti-gbm nephritis |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421516/ https://www.ncbi.nlm.nih.gov/pubmed/25949452 http://dx.doi.org/10.1093/ndtplus/sfq085 |
| work_keys_str_mv | AT mutsaerspim additionalantibodysuppressionfromrituximabaddedtoconventionaltherapyinsevererefractoryantigbmnephritis AT seltenheidi additionalantibodysuppressionfromrituximabaddedtoconventionaltherapyinsevererefractoryantigbmnephritis AT vandambastiaan additionalantibodysuppressionfromrituximabaddedtoconventionaltherapyinsevererefractoryantigbmnephritis |